Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2020, Vol. 25 ›› Issue (7): 775-783.doi: 10.12092/j.issn.1009-2501.2020.07.009

Previous Articles     Next Articles

Function and regulation of miRNAs associated with Parkinson's disease

LU Chenyu 1, YANG Jun 1,2, LIU Yixi 1,3, ZHENG Yun 1   

  1. 1 Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming  650093, Yunan, China; 2 Xishuangbanna Tropical Botanical Garden, Chinese Academy of Sciences, Xishuangbanna 666303 Yunan, China; 3 The First Affilitaed Hospital of Kunming Medical University, Kunming 650000,  Yunan, China
  • Received:2020-04-20 Revised:2020-05-25 Online:2020-07-26 Published:2020-07-31

Abstract: Parkinson's disease (PD) is a common neurological degenerative disease in the elderly people. The causes of PD are complicated, and its pathogenesis is still unknown. At present, it is generally believed that the occurrence of PD is related to multiple factors such as environment, genetics and age. microRNAs (miRNAs) are endogenous small non-coding RNAs that are involved in regulating about one-third of genes in the human genome at post-transcription level. A large number of studies have shown that miRNAs play important roles in PD. This review discusses recent researches on miRNAs relevant to PD, and summarizes the specific expression of miRNAs in the pathogenesis and diagnosis of PD.

Key words: Parkinson's disease, miRNA, biomarkers, treatment

CLC Number: